NewSquare Capital LLC cut its position in shares of UnitedHealth Group Inc. (NYSE:UNH) by 9.1% during the second quarter, Holdings Channel reports. The fund owned 840 shares of the healthcare conglomerate’s stock after selling 84 shares during the period. NewSquare Capital LLC’s holdings in UnitedHealth Group were worth $119,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently made changes to their positions in UNH. Dodge & Cox increased its stake in shares of UnitedHealth Group by 9.6% in the first quarter. Dodge & Cox now owns 15,183,189 shares of the healthcare conglomerate’s stock worth $1,957,113,000 after buying an additional 1,324,136 shares during the last quarter. BlackRock Fund Advisors increased its stake in shares of UnitedHealth Group by 1.0% in the first quarter. BlackRock Fund Advisors now owns 13,712,983 shares of the healthcare conglomerate’s stock worth $1,767,604,000 after buying an additional 135,025 shares during the last quarter. BlackRock Group LTD increased its stake in shares of UnitedHealth Group by 0.7% in the first quarter. BlackRock Group LTD now owns 9,889,989 shares of the healthcare conglomerate’s stock worth $1,274,820,000 after buying an additional 72,100 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of UnitedHealth Group by 1.8% in the first quarter. Geode Capital Management LLC now owns 7,876,841 shares of the healthcare conglomerate’s stock worth $1,013,308,000 after buying an additional 142,423 shares during the last quarter. Finally, Nordea Investment Management AB increased its stake in shares of UnitedHealth Group by 2.9% in the second quarter. Nordea Investment Management AB now owns 6,614,509 shares of the healthcare conglomerate’s stock worth $933,969,000 after buying an additional 186,653 shares during the last quarter. Institutional investors own 85.78% of the company’s stock.
UnitedHealth Group Inc. (NYSE:UNH) traded down 0.38% during mid-day trading on Friday, hitting $140.51. 2,801,957 shares of the stock were exchanged. The company has a 50-day moving average of $138.79 and a 200-day moving average of $135.32. The stock has a market capitalization of $133.82 billion, a PE ratio of 21.99 and a beta of 0.57. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $144.48.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.89 by $0.07. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The business had revenue of $46.50 billion for the quarter, compared to the consensus estimate of $45.05 billion. On average, equities analysts predict that UnitedHealth Group Inc. will post $7.92 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were given a $0.625 dividend. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 annualized dividend and a yield of 1.78%. UnitedHealth Group’s payout ratio is presently 39.12%.
A number of analysts have weighed in on the company. Barclays PLC increased their price target on UnitedHealth Group from $151.00 to $164.00 and gave the stock an “overweight” rating in a report on Wednesday, July 20th. Credit Suisse Group AG restated a “buy” rating on shares of UnitedHealth Group in a research note on Friday, June 10th. Leerink Swann restated a “buy” rating on shares of UnitedHealth Group in a research note on Friday, June 10th. Royal Bank Of Canada raised their target price on UnitedHealth Group from $157.00 to $165.00 and gave the company an “outperform” rating in a research note on Wednesday, July 20th. Finally, Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 target price for the company in a research note on Friday, July 22nd. One equities research analyst has rated the stock with a hold rating, twenty-four have issued a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $154.96.
In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares in the company, valued at $271,100,350.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.65% of the stock is currently owned by company insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.